Our Team

We leverage Big Data to save lives.

Experienced, Multidisciplinary Team of Clinicians and AI Scientists

CEO, Co-Founder

Gal Salomon

Prior to founding CLEW, Mr. Salomon founded Sansa Security (formerly Discretix) and led the company as CEO from inception until August 2010. He then served as its active Chairman until the acquisition by ARM. During this time, he was a Venture Partner at Pitango Venture Capital. Prior to founding Discretix, Mr. Salomon served in multiple positions in DSP Communications (NYSE: DSP) and Intel. Mr. Salomon holds a B.Sc. in Electrical Engineering and an MBA.

VP Product, Co-Founder

Avigdor Faians

Mr. Faians brings more than twenty years of experience in design management and system architecture for the networking, communications and consumer electronics markets. He served as CTO of WAN communications at Mindspeed Technologies and VP R&D at Techtium. Mr. Faians holds a B.Sc. in Physics, cum laude, from Ben-Gurion University of the Negev and an Electrical Engineering degree from the Technion – Israel Institute of Technology.

Chief Commercial Officer

Mitch Steiner

Mr. Steiner has spent more than 30 years in the healthcare industry with a passion for innovative, patient-centered technologies. Prior to joining CLEW Mr. Steiner created and led the Pharmacy GPO business for Provista, a Vizient company. Early in his career he held several roles with Hill-Rom, a worldwide leading provider of medical technologies and related services. Later he was the owner and managing partner for two boutique service and product companies. Returning to medical devices, he has led several teams in both startups and large organizations delivering cutting edge healthcare device technologies and services.


Elisha Ben-Zvi

Mr. Elisha Ben-Zvi brings a passion for connecting smart engineers to create innovative products. He has 20 years of experience building large-scale solutions in Big Data, security, and networking at Akamai, Contendo, and SAP. Prior to joining CLEW, Mr. Ben-Zvi served as senior director at Akamai, where he led international engineering, research, and data science teams delivering enterprise and web security products, and took an active part in scaling-up the company’s security business. Mr. Ben-Zvi holds a B.Sc. from the Academic College of Tel Aviv-Jaffa.

Chief Scientist

Prof. Assaf Zeevi

Prof. Ze’evi is the Vice Dean for Research and the Henry Kravis Professor of Business at the Graduate School of Business, Columbia University. His research is broadly focused on the formulation and analysis of mathematical models of complex systems. Ze’evi received his B.Sc. and M.Sc. (1997) Cum Laude from the Technion – Israel Institute of Technology, and subsequently his Ph.D. (2001) from Stanford University. In 2001, he joined the faculty of the Business School at Columbia University.

Medical Director

Dr. Itai Pessach

Dr. Pessach is an Assistant Professor of Pediatrics at the Tel-Aviv University and a Deputy Director at Safra Children’s Hospital, Sheba Medical Center. He is certified in allergy immunology and in pediatric critical care. He has a broad background in basic and clinical research and has published extensively in the fields of pediatric immunology and critical care. Dr. Pessach holds MD and PhD degrees from the Ben-Gurion University and has trained both at Sheba Medical Center and at Children’s Hospital Boston, Harvard Medical School.

VP Clinical Development

Dr. Ofer Chen, MD MPA

Dr. Chen received his M.D. from the Hebrew University of Jerusalem School of Medicine, and is certified in both internal medicine and in healthcare management. He has a Master’s degree in public administration from Harvard University’s Kennedy School of Government, and is a Fellow of Harvard’s Center for Public Leadership and a Wexner Foundation Fellow.
Prior to joining Clew Medical, Ofer has served in various leadership positions in the healthcare system, including deputy director of Assuta Ashdod University Hospital and Head of Community Healthcare in Maccabi Healthcare Services, Israel’s second largest HMO.

VP Finance

Limor Lev

Ms. Lev joined CLEW as VP Finance in 2019 and has extensive corporate finance and legal experience. Prior to joining CLEW, she served as CFO at Audioburst and Acousticeye with overall responsibility for finance, legal and human resources as well as preparation of the company’s business plan, strategy and business model. Prior to that she served as VP Finance and Legal at Collactive, and held a variety of finance, business and strategy roles at Comverse and Amdocs. Ms. Lev holds an M.A. in Economics from Tel Aviv University.

Advisory Board

Emory University School of Medicine

James M. Blum, MD

Dr. Blum is an NIH funded investigator and recognized expert in perioperative ARDS. He received national awards from the IARS and SOCCA. He served on several committees at SCCM, USCIITG, and has been an invited lecturer at multiple institutions, USCIITG, SCCM, IARS, and ASA. He is an active reviewer for multiple journals in both anesthesiology and critical care medicine. Blum is recognized as a national leader in critical care. His research focuses on perioperative lung injury and large datasets for outcomes research and waveform analysis.


Beth Israel Deacones, Boston, MA

Daniel Talmor, MD

Prof. Talmor is Professor of Anesthesia at Harvard Medical School and Chairman for Critical Care Medicine in the Department of Anesthesia, Critical Care, and Pain Medicine at Beth Israel Deaconess Medical Center in Boston. His fields of research include intensive care outcomes and echocardiography in the ICU. He also brings an interest in the application of data and analytics to the improvement of patient outcomes. Dr. Talmor is a graduate of Ben-Gurion University Medical School and has lectured extensively both nationally and internationally on topics relating to anesthesia and critical care.

Brigham & Women, Boston, MA

David Bates, MD

Prof. Bates is Senior Vice President for Quality and Safety and Chief Quality Officer for both the Brigham and Women’s Hospital and the Brigham and Women’s Physicians Organization. He is a practicing general internist who maintains positions at Brigham and Women’s Hospital, Harvard Medical School and Harvard School of Public Health, where he co-directs the Program in Clinical Effectiveness. Prof. Bates is a graduate of Stanford University and the Johns Hopkins School of Medicine.

Assuta Medical Center, Israel

Eran Segal, MD

Dr. Segal is the Director for the department of Anesthesia, Intensive Care and Pain Medicine at Assuta Medical Centers in Israel. Prior to joining Assuta, Dr. Segal was the Director of Critical Care at Sheba Medical Center in Israel.

Tel Aviv Medical Center, Israel

Idit Matot, MD

Prof. Matot is the Chairwoman of the Division of Anesthesia, Critical Care and Pain Medicine at Tel Aviv Medical Center in Israel. She received her M.D from the Hebrew University School of Medicine, Jerusalem and was a senior anesthesiologist for 14 years at Hadassah Medical Center. Her research focus is perioperative outcome (clinical) and liver perfusion and regeneration (experimental).

University of Chicago, Chicago, IL

Michael F. O’Connor, MD

Prof. O’Connor is the Director of Critical Care Medicine at the University of Chicago Medical Center. As an anesthesiologist and intensivist, Dr. O’Connor spent much of the past 23 years working in intensive care units, including the Burn ICU, Surgical ICU, Medical ICU, and Cardiothoracic ICU. His wide range of clinical interests includes improving the performance of alarms in the ICU and predicting decompensation in ward patients. As a leader of the initiative to create ACLS guidelines for the perioperative setting, Dr. O’Connor has authored guidelines as well as multiple books and chapters on various aspects of Critical Care.

Harvard Medical School

John D. Halamka MD

Dr. Halamka currently serves as Executive Director of Beth Israel Lahey Health Exploration Center. He also leads innovation for Beth Israel Lahey Health, serves as Chairman of the New England Healthcare Exchange Network (NEHEN), is the International Healthcare Innovation professor at Harvard Medical School, and is a practicing emergency physician. Previously, Dr. Halamka served as CIO of Beth Israel Deaconess Healthcare System.

Board of Directors

CEO, Co-Founder

Gal Salomon

Prior to founding CLEW, Mr. Salomon founded Sansa Security (formerly Discretix) and led the company as CEO from inception until August 2010. He then served as its active Chairman until the acquisition by ARM. During this time, he was a Venture Partner at Pitango Venture Capital. Prior to founding Discretix, Mr. Salomon served in multiple positions in DSP Communications (NYSE: DSP) and Intel. Mr. Salomon holds a B.Sc. in Electrical Engineering and an MBA.

Barbara Lubash

Barbara Lubash has specialized in healthcare IT and services sectors over her career as a venture investor, operating executive, and professional board member. She is Co-founder and Managing Director of Versant Ventures Funds I-III. Prior to Versant, she was a Venture Partner at Crosspoint Ventures. She is Chair of the Board of the  California Health Care Foundation (CHCF), and serves on boards of RedBrick Health and Advanced ICU Care.  Prior boards include Vantage Oncology (now McKesson), Concerto Health (FKA Fidelis SeniorCare), CodeRyte (observer), Concuity, Cogent (now Cogent/HMG), Titan Health. She has taken a leadership role in her VC sector, founding the CEO conference now known as the HEP Summit, and advised CHCF management in establishing  one of the first health services/IT Program Related (impact) Investment strategies in the U.S.  She was named 2014 Director of the Year by the OC Forum for Corporate Directors, and is a member of the Partners HealthCare (Boston) Innovation Advisory Board. Her earlier operating career includes management roles at Hewlett Packard, Harvard Community Health Plan, Pacific Review Services (div PacifiCare/United), and Private Healthcare Systems (PHCS). Barbara holds a Master’s in Health Policy and Management from Harvard University and a B.S. in Psychology from Tufts University.

Ittai Harel

Ittai Harel is a Managing General Partner at Pitango Venture Capital.
He brings 15 years of operating and management roles experience, and over ten years of experience in venture capital. His investment focus is on venture stage investments in Tech & Healthcare and includes Digital Health, Health-IT and MedTech.

Before joining Pitango, Ittai headed up Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) and served as Executive Vice President at IDGene Pharmaceuticals.

He also served as Vice President of Business Development at IDEXX Laboratories (NASDAQ: IDXX).

Ittai currently serves on the Board of Directors of LifeBond, DouxMatokEarlySenseMedisafeClew Medical and Vertos Medical, and serves as Chairman of the Board at LifeBond and EarlySense
Ittai holds a B.Sc. in Chemical Engineering and Biotechnology from Ben-Gurion University, and an MBA from the MIT Sloan School of Management.

Lihu Avitov

Lihu brings 17 years of experience in healthcare management. Previously Mr. Avitov  served 3.5 years as Angioslide CEO between 2011-2015.
Prior to Angioslide he served as an EVP at XT Investments ech, one of Israel’s leading private equity firms, heading the healthcare team.

Prior to that, he served as CEO of Naiot Venture Accelerator, and as General Manager of Rimlon, a medical device company in the orthopedics field.
At XT and Naiot he led various investments in innovative healthcare technologies and played an active role in their day-to-day management. In 2007 Mr. Avitov co-founded PainReform. Mr. Avitov holds a bachelor’s degree in Economics and Management, and a master’s degree from the Department of Industrial Engineering and Management at the Technion – Israel Institute of Technology in Haifa, Israel.

Pierre-Yves Antier

Graduate engineer with a Master’s degree in actuarial science, Pierre-Yves Antier has more than 15 years of experience in the insurance industry with strong international background. In 2014, he joined SHAM, now RELYENS Group, as Head of International Development to implement insurance and risk management activities for Healthcare actors in Spain, Italy and Germany. In connection with the new strategy of RELYENS Group, in January 2019, he assume the position of Head of Strategy, Innovation and Transformation to consider the evolution of the client and insurance universe for Healthcare actors and local government